section 8
on 10 Aug 2018
Last Applicant/ Owned by
SUITE 200
SEATTLE
WA
98102
Serial Number
85094283 filed on 27th Jul 2010
Registration Number
4078890 registered on 03rd Jan 2012
Correspondent Address
KEVIN S COSTANZA
Filing Basis
1. use application currently
Disclaimer
NO DATA
Micro RNA targeted drug development and research in the field of biotech therapeutics; development of RNA based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, including cancer, fibrosis, liver disease, and renal diseases
Micro RNA targeted drug development and research in the field of biotech therapeutics; development of RNA based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, including cancer, fibrosis, liver disease, and renal diseases
31st Jul 2008
31st Jul 2008
No 85094283
No Service Mark
No 660130.201
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 10th Aug 2018 | CANCELLED SEC. 8 (6-YR) |
| 03rd Jan 2017 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 22nd Feb 2012 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 03rd Jan 2012 | REGISTERED-PRINCIPAL REGISTER |
| 29th Nov 2011 | TTAB RELEASE CASE TO TRADEMARKS |
| 29th Nov 2011 | OPPOSITION DISMISSED NO. 999999 |
| 29th Nov 2011 | OPPOSITION TERMINATED NO. 999999 |
| 28th Apr 2011 | OPPOSITION INSTITUTED NO. 999999 |
| 09th Feb 2011 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 11th Jan 2011 | PUBLISHED FOR OPPOSITION |
